Attached files
| file | filename |
|---|---|
| 8-K - 8-K - ROCKET PHARMACEUTICALS, INC. | d500721d8k.htm |
Exhibit 16.1
March 21, 2018
Securities and Exchange Commission
Washington, D.C. 20549
Commissioners:
We have read Rocket Pharmaceuticals, Inc.’s statements included under Item 4.01 of its Form 8-K filed on March 21, 2018 and we agree with such statements concerning our firm.
/s/ RSM US LLP